Navigation Links
TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
Date:11/24/2008

TomoTherapy Incorporated (NASDAQ: TOMO), producer of the HiArt treatment system for advanced radiation therapy, today announced that Rafael (Ralph) Vaello will join the company as vice president of global sales, effective December 1, 2008. Mr. Vaello, who will report to TomoTherapy CEO Fred Robertson, M.D., has spent the previous seven years leading the sales and field marketing group for Philips Healthcare’s Oncology Imaging division.

MADISON, Wis. (Business Wire EON) November 24, 2008 -- "Ralph is an experienced, results-oriented sales leader. He has demonstrated repeated success at developing world-class sales organizations that meet or exceed their performance goals," said Dr. Robertson. "We are confident that Ralph's deep industry experience and strong management style, combined with our technology's recognized edge in the treatment of cancer patients, will accelerate our market penetration."

  • Vaello brings more than 15 years of sales expertise in the oncology and imaging industries to TomoTherapy, where he will be responsible for enhancing sales performance and expanding the company's global market presence.

Prior to joining TomoTherapy, Mr. Vaello served as vice president, sales and field marketing, for Philips Healthcare's Oncology Imaging division, where he exceeded aggressive budget plans in orders, sales and margin attainment. Mr. Vaello was previously director, global sales manager, for Marconi Medical Systems' Oncology division. Prior to that, he held various imaging and oncology sales positions for Picker International.

"TomoTherapy offers a revolutionary, efficient and versatile tool in the arsenal against cancer. The success in this battle depends on innovative technology, like the HiArt system, that enables aggressive treatment options and individualized patient care," said Mr. Vaello. "I'm very excited to join the company at such a promising time in the field of cancer treatment."

Shawn Guse, who held the role of interim vice president of global sales since August 25, 2008, will take on other executive responsibilities within the organization, including continuing as the CEO of TomoTherapy's proton therapy development subsidiary, Compact Particle Acceleration Corporation.

"Shawn has stepped in and provided valuable leadership in a critical role during his transition," said Dr. Robertson. "We appreciate Shawn's versatile talents and excellent leadership skills."

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy HiArt treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HiArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and HiArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

Read the full story at http://www.prweb.com/releases/vice_president/global_sales/prweb1664754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MUSCs Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients
2. Medical Manufacturer TomoTherapy Implements SAP Solution in Only 16 Weeks
3. TomoTherapy Concludes Treatment Quality Challenge
4. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
5. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
6. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
7. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
8. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
9. Mediware Names Thomas K. Mann Chief Executive Officer
10. Cleveland-based Health Care Tech Company Within3 Names New CEO
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 TomoTherapy Names Rafael Vaello Vice President of Global Sales :  Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries 
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology: